Spencer Pharmaceutical Begins Process for OTCBB Listing
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: 1 minute
According to the company, it is imperative in today's economy to be fully reporting to provide shareholders with maximum transparency.
"Management's objectives are focused on developing a responsible and cohesive strategy to develop and roll out our drug delivery system as shown with the recent addition of Dr. Lachance, who will be spearheading our Regulatory Affairs goals and objectives," stated Dr. Max Arella, President of Spencer Pharmaceutical Inc. In addition, "The board of directors at its most recent meeting moved to begin the process to upgrade its listing to the OTCBB. Naturally, every move, be it to the NASDAQ or above, begins with this first step to start the process. We are building a team that is committed in developing a sustainable business for our shareholders," further added Dr. Arella.
About Spencer Pharmaceutical Inc.
Spencer Pharmaceutical Inc. is a US-based Pharmaceutical Research and Development Corporation, which is developing innovative drug release and absorption systems for the treatment of metabolic diseases such as diabetes and metabolic syndrome.
Important Information About Forward-Looking Statements in this press release may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate," "believe," "estimate," "expect," "intend" and similar expressions, as they relate to the company or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above. In addition, such statements could be affected by risks and uncertainties related to the exploration for and development of mineralized material, product demand, market and customer acceptance, competition, pricing and development difficulties, as well as general industry and market conditions and growth rates and general economic conditions. Any forward-looking statements speak only as of the date on which they are made, and the company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release. Information on the company's website does not constitute a part of this release.
"Management's objectives are focused on developing a responsible and cohesive strategy to develop and roll out our drug delivery system as shown with the recent addition of Dr. Lachance, who will be spearheading our Regulatory Affairs goals and objectives," stated Dr. Max Arella, President of Spencer Pharmaceutical Inc. In addition, "The board of directors at its most recent meeting moved to begin the process to upgrade its listing to the OTCBB. Naturally, every move, be it to the NASDAQ or above, begins with this first step to start the process. We are building a team that is committed in developing a sustainable business for our shareholders," further added Dr. Arella.
About Spencer Pharmaceutical Inc.
Spencer Pharmaceutical Inc. is a US-based Pharmaceutical Research and Development Corporation, which is developing innovative drug release and absorption systems for the treatment of metabolic diseases such as diabetes and metabolic syndrome.
Important Information About Forward-Looking Statements in this press release may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate," "believe," "estimate," "expect," "intend" and similar expressions, as they relate to the company or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above. In addition, such statements could be affected by risks and uncertainties related to the exploration for and development of mineralized material, product demand, market and customer acceptance, competition, pricing and development difficulties, as well as general industry and market conditions and growth rates and general economic conditions. Any forward-looking statements speak only as of the date on which they are made, and the company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release. Information on the company's website does not constitute a part of this release.
